Clinical Course of Hepatitis B Viral Infection in Patients Undergoing Anti-Tumor Necrosis Factor α Therapy for Inflammatory Bowel Disease
Journal
Gut and liver
Journal Volume
16
Journal Issue
3
Pages
396
Date Issued
2022
Author(s)
Lee, Ji Min
Lee, Kang-Moon
Ye, Byong Duk
Mao, Ren
Kim, Hyun-Soo
Park, Soo Jung
Park, Sang Hyoung
Oh, Eun Hye
Im, Jong Pil
Jang, Byung Ik
Kim, Dae Bum
Takeuchi, Ken
Abstract
Little is known about the clinical course of hepatitis B virus (HBV)-infected patients undergoing anti-tumor necrosis factor α (TNF-α) therapy for inflammatory bowel disease (IBD). We aimed to investigate the clinical course of HBV infection and IBD and to analyze liver dysfunction risks in patients undergoing anti-TNF-α therapy.
Subjects
Anti-tumor necrosis factor alpha; Hepatitis B virus; Inflammatory bowel disease; Reactivation
Type
journal article